← FDA Drug Approvals (Drugs@FDA)

DANZITEN

NDA · New Drug Application · Sponsor: AZURITY · Approved 2024-11-07

Drug application

FDA Application #

NDA219293

Application type

New Drug Application

Brand name

DANZITEN

Generic name

NILOTINIB

Active ingredients

NILOTINIB TARTRATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AZURITY

Manufacturer

Azurity Pharmaceuticals, Inc.

First approval

2024-11-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown